Skip to main content
Caplight Logo









RenewalBio

RenewalBio

Private
IsraelHealthcare & Life Scienceshttps://www.renewal.bio/

Last Round

Seed

Nov 11, 2025

Total Funding Raised

$400,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RenewalBio is a biotechnology company that develops a synthetic-embryo and stem-cell therapeutics platform intended to generate transplantable tissues and rejuvenated cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

stem cell therapyregenerative medicinesynthetic embryoscellular therapiesorgan regenerationiPSCsinduced pluripotent stem cellsembryo modelsautologous cell therapyStembroid platformtissue engineeringcell therapy platformhematopoietic stem cellsage-related diseasesinfertility treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RenewalBio Comparables

Compare RenewalBio with similar companies based on industry and business-model similarity.

RenewalBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stratus Therapeutics
73%
LyGenesis
71%
Fujifilm Holdings Corporation
69%

RenewalBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 11, 2025

RenewalBio Investors

Notable investors and investment history

RenewalBio investors
InvestorRounds
LongGame VenturesSeed
Calm VenturesSeed
YZi LabsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 51% MoM, reaching 2.4K.

  • Apr 16, 2026

    Monthly visitors increased 281% MoM, reaching 666.

RenewalBio Filings

Explore SEC and related filing metadata, where available.

RenewalBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RenewalBio's valuation, stock price, and market status.

Is RenewalBio a public or private company?

RenewalBio is a private company.

What is the current stock price of RenewalBio?

RenewalBio is a private company with no public stock price. No recent secondary market data is available.

How much is RenewalBio worth (valuation)?

Valuation information for RenewalBio is not publicly available.

Can I buy RenewalBio stock?

RenewalBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RenewalBio's last funding round?

RenewalBio's most recent funding round was Seed on November 11, 2025.

Who are the main investors in RenewalBio?

Key investors in RenewalBio include YZi Labs.

Will RenewalBio IPO soon?

No public IPO plans have been announced for RenewalBio.

How can I track RenewalBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RenewalBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range19
Year Founded2022
Last FundingNov 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?